Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 16
	QLoRA Alpha: 24.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: The results suggest that BF% is a more sensitive measure of undernutrition in neonates than birth weight percentiles. The prevalence of low BF% (defined as 1 SD below the mean) is similar to that reported for birth weight <10th percentile, but with a stronger association with neonatal morbidity. This suggests that BF% may be a better measure of undernutrition in newborns because it identifies infants at greater risk of morbidity due to nutrient deprivation. These findings support the need for continued monitoring of BF% in addition to birth weight percentiles when assessing neonatal health status.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.8
Reasoning:
The assistant's answer correctly conveys the study's main conclusion that BF% is more closely associated with neonatal morbidity than birth weight percentiles and therefore may better identify undernourished neonates at risk. It appropriately notes the stronger association with morbidity. Minor weaknesses: it uses the term "more sensitive" without reporting effect sizes or CIs, omits the specific point that BF% can identify appropriately grown but undernourished infants (and exclude small infants not at risk), and makes a mild recommendation (continued monitoring) that slightly extends beyond the presented results.

conciseness: 0.8
Reasoning:
The assistant's reply is concise and directly answers the question, summarizing the study's key finding (stronger association of BF% with morbidity than birth weight percentiles). It is slightly repetitive and adds a recommendation ("continued monitoring") that goes beyond a strictly concise answer to the asked question.

relevance: 0.9
Reasoning:
The assistant's reply is relevant and directly answers the question: it states that BF% appears to be a better measure than birth weight percentiles, and it refers to study findings (prevalence of low BF% similar to small-for-gestational-age frequency and a stronger association with neonatal morbidity). The answer accurately reflects the study's main comparisons, though it could be slightly stronger by citing the reported effect sizes (ORs and CIs) or the exact prevalence number (73 per 1,000). Overall the response stays on-topic and grounds its conclusion in the provided context.

coherence: 0.8
Reasoning:
The assistant's reply is coherent and well-structured: it summarizes the study's main finding (BF% shows a stronger association with neonatal morbidity than birth weight percentiles) and gives a reasonable conclusion (BF% may be a better measure and could be used alongside birth weight). It is concise and logically follows from the reported odds ratios. Minor weaknesses: it omits quantitative detail (the actual ORs and prevalence), does not mention study limitations or the specific advantage of identifying appropriately grown but undernourished infants, and is slightly more definitive than the data warrant without caveats.

helpfulness: 0.8
Reasoning:
The assistant's reply is concise and correctly conveys the study's main finding: BF% shows a stronger association with neonatal morbidity than birth weight percentiles and could therefore better identify undernourished neonates at risk. It correctly interprets the reported odds ratios and reasonably concludes that BF% has potential clinical value alongside birth weight. 

Shortcomings: the answer slightly overgeneralizes by calling BF% "more sensitive" without clarifying the population and study-specific definitions (term neonates, BF% defined as 1 SD below the mean, measured by air displacement plethysmography). It also omits mention that BF% can identify neonates who are appropriately grown by weight but still undernourished and can exclude small neonates not at risk — a useful nuance stated in the ground truth. Mentioning feasibility and that conclusions may be population-specific would improve the response.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The results obtained from this study show that Charcot neuroarthropathy with critical limb ischemia can be treated successfully by a combined endovascular, surgical and orthopedic approach. The use of this approach allows us to obtain good results in terms of limb preservation. This finding could represent an alternative to other treatments currently proposed. Further studies are needed to confirm these findings and to determine whether this approach is applicable to the whole population of diabetic patients affected by ischemic Charcot neuroarthropathy.
This combined therapy should be considered as an option in the treatment of Charcot neuroarthropathy, especially if it is associated with critical limb ischemia. It is also important to consider the possibility of performing the different treatments in a staged manner, in order to avoid further damage to the foot.
In conclusion, this paper shows that a combined endovascular, surgical and orthopedic approach could be effective in treating ischemic Charcot neuroarthropathy with critical limb ischemia. However, more studies are needed to confirm these results and to establish whether this approach is applicable to all diabetic patients with ischemic Charcot neuroarthropathy.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.9
Reasoning:
The assistant’s reply accurately reflects the study findings: it correctly reports that a combined endovascular (revascularization), surgical and orthopedic approach yielded high limb-salvage rates in ischemic Charcot neuroarthropathy and appropriately frames the result as promising but needing confirmation in larger series. It is cautious rather than categorical about the necessity of revascularization (the ground truth states revascularization is required to support surgery and avoid amputation), which is reasonable given the small retrospective series; the response is slightly repetitive but factually correct.

conciseness: 0.4
Reasoning:
The assistant's reply conveys the main finding (combined endovascular, surgical and orthopedic treatment can preserve limbs in ischemic Charcot neuroarthropathy) but is repetitive and wordy, restating the same conclusion multiple times without a clear, direct answer to whether ischemic Charcot foot is a distinct entity requiring different treatment. It could be much more concise — one or two sentences would suffice to state the implication and limitation.

relevance: 0.7
Reasoning:
The assistant’s reply is relevant and addresses the question by stating that ischemic Charcot neuroarthropathy can require a different, combined treatment (endovascular revascularization plus surgical/orthopedic care) when critical limb ischemia is present—which matches the study context. However, it misses concrete data from the paper (for example the 90% limb-salvage rate and mean healing time ~197 days) and does not explicitly state as strongly as it could that ischemic Charcot represents a distinct management scenario that often necessitates revascularization. The response is slightly repetitive and cautious without adding new evidence.

coherence: 0.8
Reasoning:
The assistant's reply is generally coherent and well organized: it summarizes the study findings, draws a reasonable conclusion that combined endovascular, surgical and orthopedic treatment is a viable option for ischemic Charcot neuroarthropathy, and appropriately calls for further studies. It aligns with the ground truth that revascularization is necessary to support surgical/orthopedic treatment and can help avoid amputation. Weaknesses: it is somewhat repetitive, does not explicitly state whether ischemic Charcot foot should be considered a different disease entity (the question asks that directly), and it omits specific outcome data from the study (limb salvage rate, healing time) that would strengthen the answer.

helpfulness: 0.6
Reasoning:
The assistant's reply is generally accurate and appropriately cautious: it summarizes the study's finding that a combined endovascular (revascularization), surgical, and orthopedic approach can preserve limbs in ischemic Charcot neuroarthropathy and correctly calls for further study. However, it is somewhat repetitive and vague, and it does not explicitly state the key clinical point from the ground truth that ischemic Charcot foot represents a distinct clinical situation that often requires revascularization to support surgical/orthopedic treatment and reduce amputation risk. The answer also omits study details (e.g., limb-salvage rate, healing time, sample size and limitations) that would make the recommendation more informative.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: This study suggests that RH is appropriate in patients with endometrial cancer suspected to have cervical involvement. However, further studies are needed to confirm the role of RH in this patient group. In this study, RH may be associated with better oncologic outcomes than mRH or SH, but it did not show any additional benefit over other procedures. This study also showed that RH might be associated with longer operative time, more frequent blood transfusions, and more severe postoperative complications. Therefore, surgeons should consider individual patient characteristics when deciding on the optimal treatment strategy. To determine whether RH is necessary for patients with endometrial cancer suspected to have cervical involvement, prospective clinical trials comparing RH with other approaches are required. This trial demonstrated that RH provides better oncologic results than mRH or SH for endometrial cancer patients with cervical involvement. Further investigation is needed to clarify the impact of RH on the management of patients with endometrial cancer with suspected cervical involvement.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.2
Reasoning:
Short explanation: The assistant's reply contains major factual errors and internal contradictions. The GOTIC-005 study did not find a survival benefit for radical hysterectomy (RH) and specifically reported that hysterectomy type was not an independent prognostic factor for local recurrence-free survival, PFS, or OS; nonetheless the reply repeatedly claims RH provides better oncologic outcomes and "is appropriate," which contradicts the study results. The response correctly notes increased operative time, transfusion rates, and urinary complications with RH and appropriately calls for prospective trials, but the central conclusion about RH improving oncologic outcomes is incorrect.

conciseness: 0.2
Reasoning:
The assistant's reply is unclear, internally contradictory, and not concise. It repeatedly alternates between claiming RH is "appropriate" or provides "better oncologic results" and stating it shows "no additional benefit," which conflicts with the study's findings that type of hysterectomy was not an independent prognostic factor and that RH produced more perioperative and late adverse events. The answer is also repetitive and does not clearly or succinctly summarize the study's key conclusions (no survival benefit from RH; greater morbidity with RH; need for prospective trials).

relevance: 0.3
Reasoning:
The response is only partially relevant. It mentions real findings from the study (longer operative time, higher transfusion rates, more severe urinary dysfunction with RH) but contradicts the study's main conclusions by alternately claiming RH may give better oncologic outcomes and also that it shows no additional benefit. It therefore misrepresents the primary result (that type of hysterectomy was not an independent prognostic factor and RH showed no survival benefit) and is internally inconsistent.

coherence: 0.2
Reasoning:
The response is poorly coherent: it contains direct contradictions (saying RH is "appropriate" and provides "better oncologic results" while also stating it "did not show any additional benefit"), repeats points, and thus fails to present a clear conclusion aligned with the study findings. It correctly notes increased operative time, transfusions, and urinary complications with RH and appropriately calls for prospective trials, but the mixed and self-contradictory statements undermine clarity and trustworthiness.

helpfulness: 0.2
Reasoning:
Explanation: The assistant response is confusing, internally contradictory, and does not accurately convey the study's main findings. The study found that type of hysterectomy was not an independent prognostic factor and that radical hysterectomy (RH) offered no survival benefit but was associated with longer operative time, more transfusions, and more urinary dysfunction; the assistant sometimes states RH is “appropriate” or “provides better oncologic results,” which contradicts the study. The answer does correctly note higher morbidity with RH and that prospective trials are needed, but overall it fails to give a clear, accurate summary and repeats contradictory claims, reducing its helpfulness.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD are not infrequent and may be related to several factors such as inadequate preoperative preparation, excessive blood loss during the index operation, failure to establish an adequate drainage system, and poor postoperative care. These factors may result in prolonged postoperative recovery periods, increased risk of complications, and decreased patient satisfaction. Furthermore, readmissions may increase health-care costs. Although the current practice of PD has improved patient outcomes, further studies are needed to determine which factors are most critical to readmission and to develop strategies to decrease their rates. Further prospective studies could focus on identifying the key risk factors and implementing strategies to reduce readmissions. Improved understanding of these issues would help improve patient outcomes and reduce health-care expenses. Therefore, we recommend that all surgeons and institutions should be aware of the potential risks of readmission and implement strategies to reduce these risks. This could include preoperative optimization, meticulous attention to postoperative care, and close monitoring of patients for signs of complications. Additionally, institutions should continue to collect data on readmissions and share this information with other centers to facilitate standardized care. Finally, future studies should focus on the development of evidence-based guidelines for PD, which will help to improve patient outcomes and reduce readmission rates.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.2
Reasoning:
The assistant's reply is generic and offers reasonable general recommendations (preoperative optimization, close monitoring, data collection), but it fails to reflect the specific, evidence-based findings in the study: it omits that complexity of the initial resection (multivisceral resection) and pancreatic fistula were independent predictors of readmission, and it does not note that ~50% of readmissions occur within 7 days and therefore early readmission prevention should be a priority. Because it neither cites nor addresses the study's key predictors or the recommendation to focus on early readmissions, its correctness relative to the ground truth is poor.

conciseness: 0.3
Reasoning:
The assistant's reply is wordy and repetitive and fails to concisely summarize the study’s key, specific findings. It gives generic prevention advice and calls for more research but omits the main independent predictors (pancreatic fistula, complexity/multivisceral resection, prolonged initial stay, ICU admission) and the critical point that half of readmissions occur within 7 days and thus early-readmission prevention should be prioritized. Overall it does not provide a concise, study-focused answer to "can we prevent them?"

relevance: 0.3
Reasoning:
Explanation: The assistant's reply addresses the general question of preventing readmissions after PD and gives broad recommendations (preoperative optimization, careful postoperative care, monitoring, data collection). However it fails to refer to the actual findings from the provided context (notably that pancreatic fistula and complexity/multivisceral resection were independently associated with readmission, and that half of readmissions occur within 7 days). It also introduces unreferenced causes (excessive blood loss, inadequate drainage) that were not stated in the context. Because it does not ground its conclusions in the quoted study results or quote the key points, its relevance to the specific prompt and context is limited.

coherence: 0.4
Reasoning:
The response is coherent and organized (it states the problem, lists general contributing factors, and offers broad recommendations), but it is overly generic and repetitive. It fails to reference the study’s specific findings (notably that pancreatic fistula and complexity of resection/multivisceral resection were independently associated with readmission) and does not address the important point that half of readmissions occur early (≤7 days) or suggest targeted measures to prevent those early readmissions. Overall, it answers at a high level but lacks the study-specific, actionable conclusions that would make it directly responsive to the question.

helpfulness: 0.3
Reasoning:
The response is general and offers plausible high-level prevention ideas (preoperative optimization, careful postoperative care, monitoring, data collection), but it fails to accurately or specifically reflect the study findings. It does not identify the independent predictors shown by the data (complex/ multivisceral resection and pancreatic fistula) or note that half of readmissions occur within 7 days and therefore that efforts should prioritize preventing early readmissions. The answer also includes speculative causes (excessive blood loss, inadequate drainage) not supported by the provided results and gives only generic, non-actionable recommendations rather than targeted strategies based on the reported predictors.

================================================================================
Average correctness Score: 0.54
Average conciseness Score: 0.495
Average relevance Score: 0.525
Average coherence Score: 0.57
Average helpfulness Score: 0.51
